
    
      The purpose of this study is to evaluate the effect of two different treatment strategies on
      CV outcomes in patients with type 2 diabetes while aiming to achieve and maintain HbA1c <7.0%
      in both groups. Only patients who have recently experienced an acute MI will be considered
      for participation in this trial.
    
  